Sentences with phrase «direct cell replacement»
In 2017, ViaCyte, Inc. announced the allowance of clinical testing for its PEC - Direct cell replacement product candidate for high - risk type 1 diabetes.
http://viacyte.com/
JDRF and ViaCyte Announce Support for Development of PEC - Direct Cell Replacement Therapy for Type 1 Diabetes
Not exact matches
iPSCs directed to differentiate into specific cell types offer the possibility of a renewable source of replacement cells and tissues to treat ailments, including Parkinson's disease, spinal cord injury, heart disease, diabetes, and arthritis.
In the long run, scientists hope to use organoids and induced pluripotent stem cells to engineer tissue replacements in patients suffering from diseases that currently are treated with direct transplants of fetal tissue.
While it may be that precursor cell transplantation is of potential use in astrocyte replacement in neurological disorders such as ALS [56], our results demonstrate the importance of determining whether direct transplantation of astrocytes themselves provides greater benefit.
With the STEP ONE trial underway, and the addition of W. L. Gore & Associates as collaborators to optimize the Encaptra ® cell delivery system, ViaCyte felt that the PEC - Direct approach might be the most rapid way to get the invaluable PEC - 01 cell replacement therapy to those who need it most.
«JDRF remains dedicated to accelerating the delivery of beta cell replacement therapies to the T1D community, and we commend ViaCyte in its announcement of the first patients to be implanted with the PEC - Direct islet cell replacement therapy,» said Derek Rapp, JDRF President and Chief Executive Officer.
The Company's pluripotent stem cell - derived islet cell replacement therapy, the PEC - Direct ™ product candidate, has the potential to be a breakthrough treatment for high - risk type 1 diabetes.
«The PEC - Direct islet cell replacement therapy is designed to help patients with the most urgent medical need.»
San Diego, August 1, 2017 — ViaCyte, Inc., a privately - held, leading regenerative medicine company, announced today that the first patients have been implanted with the PEC - Direct ™ product candidate, a novel islet cell replacement therapy in development as a functional cure for patients with type 1 diabetes who are at high risk for acute life - threatening complications.
Although this possibility has not yet attracted as much attention as the ideas of cell replacement, personalized medicine and other more direct clinical applications, hESCs are expected to be superior to most commonly used cell - culture models of drug discovery which employ tumor - derived or immortalized cell lines or primary cell culture.
A lead engineer from the Department of Energy whose team is testing fuel cell cars said in 2011 that the potential appeal is that «these are full - function vehicles with no limitations on range or refueling rate so they are a direct replacement for any vehicle.